Cervical Intraepithelial Neoplasm

Slides:



Advertisements
Similar presentations
Management of Abnormal Pap Smears and Cervical Dysplasia Jennifer L. Ragazzo, M.D. Department of Obstetrics and Gynecology Division of Womens Primary Healthcare.
Advertisements

MANAGEMENT OF ABNORMAL PAP SMEAR
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Updates on Pap Smear Guidelines 2014
Evolution of Neoplasia The Uterine Cervix As a Model Raj C. Dash, MD Duke University Medical Center Durham, North Carolina.
Sample Taker Training Cervical Cytology & Management of Abnormalities.
Cervix Dr. Raid Jastania. Cervical Cancer Screening HPV infection Pre- Cancerous Dysplasia Cancer years.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Cervical Cancer: Molecular Impact of an Infectious Disease.
Benign Conditions Of The Cervix Dr. Abdalla H. Elsadig MD.
Screening for Cervical Cancer
Management of Women with CIN 1 or LSIL
Spotlight on Cervical Cancer Screening
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA Roger J Rand.
Benign and premalignant disease of the cervix
Female Genital Tract 1-Vulva 2-Vagina 3-Cervix 4-Uterine corpus
Cervical Cancer Source: SEER’s Training Web Site
Cervical Cancer: Prevention and Treatment
CERVICAL CANCER IN BOTSWANA By Monkgogi Khana Khomela and Wedu King.
Diseases of cervix.
PRE-INVASIVE DISEASE OF THE CERVIX CERVICAL INTRAEPHELIAL NEOPLASIA DR. AMEL AL-SAYED Asst. Prof. & Consultant Ob/Gyne Dept.
wrong to say cervical erosion -this condition appear at ( puberty ) ( pregnancy )
Case Presentations: Pre-Invasive Cervical Neoplasia
COLPOSCOPY Cervical Screening QARC Training School October 2012.
Cytopathology: Technique and Interpretation
Cervical Cancer Screening
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
CIN & Cervical Cancer Women ’ s Hospital, School of Medicine, Zhejiang university.
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Cervical Cancer in California Janet Bates, MD MPH Research Program Director Research and Surveillance Program California Cancer Registry.
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
Cancer of Cervix Shashi. Sep-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. Potentially curable if detected early.
Abnormal Pap in Pregnancy Alexander Burnett, MD Division Gyn Oncology, UAMS April, 2006.
SoftPAP® A Novel Collection Device for Cervical Cytology.
CIN and mimics Dr Michael Coutts Consultant Gynaecological Pathologist
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
Tumors of Cervix.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
Cancer of Cervix Shashi. Oct-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. US Statistics: US Statistics: Leading.
Adult Medical-Surgical Nursing
 Cervical cancer kills about women a year.  It’s the commonest cause of death from cancer in women.it’s the commonest after breast cancer. 
Premalignant lesions of the cervix. Applied anatomy.
CERVICAL SCREENING ANGELIKA KAUFMANN, ST4, UHCW, MEDICAL STUDENT INDUCTION, 2015.
What is a Pap smear? is a medical procedure in which a sample of cells from a woman's cervix is collected and spread (smeared) on a microscope slide.
COLPOSCOPY QUESTIONS Michael R. Downs M.D. October 2004.
2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.
HPV and Pap Guidelines Jennifer Johnson MD. Objectives 1. Define the new PAP guidelines. 2. Identify the historical trends and new evidence resulting.
Cervical Pathology Nilsa C. Ramirez, MD Director of Autopsy Pathology
HPV-related anogenital cancers
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
Cytopathology Feb
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
Understanding Test Results
CERVIX.
INTRODUCTION: CERVICAL CANCER SCREENING
Cytology Codes & management Colposcopy- Management of cervical lesions
Cervical Cancer in California
Preinvasive Cervical Neoplasia
Cervical Cancer Colposcopy & Treatment
Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.
Management of the Abnormal Pap Smear.
Neoplasia of the cervix
Cervical excisional treatment of young women: A population-based study
SH-sheikhhasani Gyn-oncologist
Presentation transcript:

Cervical Intraepithelial Neoplasm Speaker: Tseng Jen-Yu

Introduction Cervical cancer was the most common malignancy in both incidence and mortality among women prior to the 20th century Incidence fallen dramatically in developed nations due to implementation of population based screening, detection, and treatment programs for pre-invasive disease

Epidemiology and Risk Factor 500,000 cases of cervical cancer diagnosed 2nd leading cause of cancer death Risk factors Sexually transmitted disease Human papilloma virus Multiple sexual partners Intercourse at early age Poor personal hygine Immunocompromise Cigarette smoking

Pathophysiology Transformation zone Metaplasia Area where glandular epithelium undergoes squamous metaplasia Metaplasia Occurs during fetal development / adolescence / and first pregnancy Columnar cells replaced by squamous cells Cells undergoing metaplasia are vulnerable to carcinogens

Bethesda System LSIL HSIL ASCUS AGUS Low grade squamous epithelial lesion HSIL High grade squamous epithelial lesion ASCUS Atypical squamous cells of undetermined significance AGUS Atypical glandular cells of undetermined significance

Terminology and Definition CIN I Mild dysplasia ( lower 1/3 of epithelium ) CIN II Moderate dysplasia ( 2/3 of epithelium ) CIN III Severe dysplasia ( upper 1/3 of epithelium / CIS ) Dysplasia Disorder maturation / Nuclear hyperchromatism Increased N/C ratio / Pleomorphism / Mitosis

CIN I Disease Profile Self limited sexually transmitted HPV infection 60% regress spontaneously 30% persistent 10 ~ 15% progress to CIN II / III 1% progress to invasive cancer

Follow up without treatment Ablation ( cryotherapy / laser ) Excision ( LEEP / Knife conization ) Follow up without treatment Pregnant women Immunosuppressed women Adolescents

CIN II / III Disease Profile 43% untreated CIN II spontaneous regression 32% untreated CIN III spontanenous regression 35% CIN II will persist 56% CIN III will persist 22% CIN II progress to CIS or invasive cancer 14% CIN II progress to CIS or invasive cancer

Follow up without treatment Ablation ( cryotherapy / laser ) Excision ( LEEP / Knife conization ) Follow up without treatment Pregnant women Adolescents

ASCUS Represent reactive / reparative changes secondary to inflammation 5% of routine Pap smears Treatment Repeat Pap smear in 4 ~ 6 months Colposcopy if repeat Pap shows ASCUS

AGUS Suspected glandular lesion that can’t be classified as reactive or neoplastic Higher risk of neoplasia ( adenocarcinoma ) 0.5 ~2.5% of routine Pap smear Treatment Colposcopy Conization + ECC

Colposcopy Acetic acid coagulation of nuclear protein preventing light to pass through the epithelium Higher nuclear density and higher concentration of protein => white intensity increase

Schiller / Lugol’s Iodine Normal, mature squamous epithelium contains abundant glycogen Produce dark brown stain Abnormal epithelium contains relatively little or no glycogen Remain relative unstained

Cryotherapy Indication Criteria Cytology / Colposcopy / ECC => No microinvasion Lesion in ectocervix Criteria CIN I / II Small lesion Ectocervix ECC negative No endocervical gland involvement

Conization Indication Unsatisfactory colposcopy Evidence of premalignant or malignant glandular epithelium Microinvasion on biopsy / colposcopy / Pap smear HSIL ( CIN II / CIN III ) Uncertainty regarding presence of microinvsaion or invasion following direct biopsy for CIn Inconsistent Pap smear and colposcopy

Cold Knife Indication Lesion extend to endocervical canal and extent not possible to confirm Extent exceeds capability of LEEP ( 1.5 cm ) Cytology shows atypical glandular cells Colposcopy suggest glandular dysplasia or adenocarcinoma Abnormal endocervical curretage

Thank You for your attention